Your browser doesn't support javascript.
loading
Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations.
Gómez-Zorita, Saioa; Milton-Laskibar, Iñaki; Eseberri, Itziar; Beaumont, Pauline; Courtois, Arnaud; Krisa, Stéphanie; Portillo, María P.
Affiliation
  • Gómez-Zorita S; Nutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.
  • Milton-Laskibar I; CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 28222 Madrid, Spain.
  • Eseberri I; BIOARABA Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
  • Beaumont P; Nutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.
  • Courtois A; CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 28222 Madrid, Spain.
  • Krisa S; BIOARABA Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
  • Portillo MP; Nutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.
Nutrients ; 15(4)2023 Feb 12.
Article in En | MEDLINE | ID: mdl-36839286
Viniferin is a phenolic compound belonging to the group of stilbenoids. In particular, ε-viniferin is a dimer of resveratrol, found in many plant genders, among which grapes (Vitis vinifera) are a primary source. Due to the fact that ε-viniferin is mainly present in the woody parts of plants, their use as a source of this bioactive compound is a very interesting issue in a circular economy. Both, in vitro studies carried out in pre-adipocytes and mature adipocytes and in vivo studies addressed in mice show that ε-viniferin is able to reduce fat accumulation. Moreover, it prevents the development of some obesity co-morbidities, such as type 2 diabetes, dyslipidemias, hypertension and fatty liver. ε-viniferin can be absorbed orally, but it shows a very low bioavailability. In this scenario, further research on animal models is needed to confirm the effects reported in a great number of studies; to determine which metabolites are involved, including the main one responsible for the biological effects observed and the mechanisms that justify these effects. In a further phase, human studies should be addressed in order to use ε-viniferin as a new tool for obesity management, as a nutraceutical or to be included in functional foods.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stilbenes / Vitis / Diabetes Mellitus, Type 2 Limits: Animals / Female / Humans / Male Language: En Journal: Nutrients Year: 2023 Document type: Article Affiliation country: España Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stilbenes / Vitis / Diabetes Mellitus, Type 2 Limits: Animals / Female / Humans / Male Language: En Journal: Nutrients Year: 2023 Document type: Article Affiliation country: España Country of publication: Suiza